All Stories

  1. Familial risk of vasospastic angina: a nationwide family study in Sweden
  2. Rare-variant collapsing and bioinformatic analyses for different types of cardiac arrhythmias in the UK Biobank reveal novel susceptibility loci and candidate amyloid-forming proteins
  3. Association between Hereditary Angioedema and Venous Thromboembolism in a Large Population-Based Case-Control Study
  4. Contribution of rare genetic variants to heart failure and cardiomyopathy in the UK Biobank
  5. Review of gene collapsing analysis for arterial and venous cardiovascular diseases
  6. The role of fibrinolysis in vascular diseases in UK biobank
  7. Lung function, respiratory symptoms and incident venous thromboembolism during a 44-year follow-up
  8. Bioinformatics Reveals Novel Diabetes Susceptibility Genes
  9. Multimorbidity can run in families—what are implications for clinical practice?
  10. Rare-variant collapsing and bioinformatic analyses for amyloidosis, dementia and Parkinson’s disease in the UK biobank reveal novel susceptibility loci
  11. Familial aggregation of multimorbidity in Sweden: national explorative family study
  12. A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
  13. Rare variation contributes to hypertension
  14. Sex‐Specific Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism in a Population‐Based Historical Cohort Study of Middle‐Aged and Older Individuals
  15. Familial Associations of Complete Atrioventricular Block: A National Family Study in Sweden
  16. Contribution of rare and common coding variants to haematological malignancies in the UK biobank
  17. 1059 FAMILIAL RISK OF DILATED AND HYPERTROPHIC CARDIOMYOPATHY: A NATIONAL FAMILY STUDY IN SWEDEN
  18. Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle‐aged and older adults: A population‐based cohort study
  19. Familial risk of dilated and hypertrophic cardiomyopathy: a national family study in Sweden
  20. Thrombotic risk determined by rare and common SERPINA1 variants in a population‐based cohort study
  21. Association between self-rated health and venous thromboembolism in Malmö Preventive Program: A cohort study
  22. Familial Mortality Risks in Patients With Ischemic Stroke: A Swedish Sibling Study
  23. Air pollution and biomarkers of cardiovascular disease and inflammation in the Malmö Diet and Cancer cohort
  24. Thrombomodulin (THBD) gene variants and thrombotic risk in a population‐based cohort study
  25. Classic Thrombophilias and Thrombotic Risk Among Middle‐Aged and Older Adults: A Population‐Based Cohort Study
  26. Thrombotic Risk Determined by Protein C Receptor (PROCR) Variants among Middle-Aged and Older Adults: A Population-Based Cohort Study
  27. Familial Segregation of Venous Thromboembolism in Sweden: A Nationwide Family Study of Heritability and Complex Segregation Analysis
  28. Thrombotic Risk Determined by STAB 2 Variants in a Population-Based Cohort Study
  29. Mitochondria-DNA copy-number and incident venous thromboembolism among middle-aged women: a population-based cohort study
  30. Risk Factors for Syncope Associated With Multigenerational Relatives With a History of Syncope
  31. Effect of mindfulness on physical activity in primary healthcare patients: a randomised controlled trial pilot study
  32. Reactome Pathway Analysis of Venous Thromboembolism, Peripheral Artery Disease, Stroke, and Coronary Artery Disease
  33. Neighborhood socioeconomic status and aortic stenosis: A Swedish study based on nationwide registries and an echocardiographic screening cohort
  34. Genetic risk factors for venous thromboembolism
  35. Mortality risks associated with sibling heart failure
  36. Risk of Stroke in Patients With Atrial Fibrillation Is Associated With Stroke in Siblings: A Nationwide Study
  37. Self-rated health and venous thromboembolism among middle-aged women: a population-based cohort study
  38. Genetics of venous thromboembolism revised
  39. J‐curve association between alcohol intake and varicose veins in Japan: The Shimane CoHRE Study
  40. Next-Generation Sequencing of 17 Genes Associated with Venous Thromboembolism Reveals a Deficit of Non-Synonymous Variants in Procoagulant Genes
  41. Heritability of glomerulonephritis: A Swedish adoption study
  42. Familial association of attention-deficit hyperactivity disorder with autoimmune diseases in the population of Sweden
  43. Outcomes associated with dual antiplatelet therapy after myocardial infarction in patients with aortic stenosis
  44. New functional test for theTFPIαcofactor activity of Protein S working in synergy withFV‐Short
  45. Association of Genetic vs Environmental Factors in Swedish Adoptees With Clinically Significant Tinnitus
  46. Association of recurrent venous thromboembolism and circulating microRNAs
  47. Cardiovascular Risk Factors Associated With Venous Thromboembolism
  48. Association of Short-Term Mortality of Venous Thromboembolism with Family History of Venous Thromboembolism and Charlson Comorbidity Index
  49. Familial Mortality Risks in Patients With Heart Failure—A Swedish Sibling Study
  50. Alpha 2-macroglobulin 5 bp insertion/deletion polymorphism increases the risk of recurrent venous thromboembolism
  51. Pilot study on increased adherence to physical activity on prescription (PAP) through mindfulness: study protocol
  52. Hospitalization rate of paroxysmal supraventricular tachycardia in Sweden
  53. Postoperative Joint Replacement Complications in Swedish Patients With a Family History of Venous Thromboembolism
  54. Characteristics and prognosis of healthy severe obesity (HSO) subjects - The Malmo Preventive Project
  55. Prevalence and in silico analysis of missense mutations in the PROS1 gene in the Swedish population: The SweGen dataset
  56. Dementia and Alzheimer's disease risks in patients with autoimmune disorders
  57. Heritability of heart failure estimated among Swedish adoptees
  58. Familial Risks of Glaucoma in the Population of Sweden
  59. Association of irritable bowel syndrome and venous thromboembolism
  60. Identification of novel diagnostic biomarkers for deep venous thrombosis
  61. Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner
  62. Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients
  63. Factor V Leiden paradox in a middle-aged Swedish population: A prospective study
  64. Family history of diabetes and its relationship with insulin secretion and insulin sensitivity in Iraqi immigrants and native Swedes: a population-based cohort study
  65. Familial Aggregation of Aortic Valvular StenosisCLINICAL PERSPECTIVE
  66. Perinatal and familial risk factors for irritable bowel syndrome in a Swedish national cohort
  67. Heritability of End-Stage Renal Disease: A Swedish Adoption Study
  68. A Swedish national adoption study of risk of irritable bowel syndrome (IBS)
  69. Heritability of Mitral RegurgitationCLINICAL PERSPECTIVE
  70. Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism
  71. Body Height and Incident Risk of Venous ThromboembolismCLINICAL PERSPECTIVE
  72. Quantification of mitochondrial DNA copy number in suspected cancer patients by a well optimized ddPCR method
  73. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study
  74. Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism
  75. Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden
  76. Seasonal variation of pulmonary embolism and age dependence
  77. Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case−control study from Sweden
  78. Identification of Genetic Aberrations in Thrombomodulin Gene in Patients With Recurrent Venous Thromboembolism
  79. A sibling based design to quantify genetic and shared environmental effects of venous thromboembolism in Sweden
  80. Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study
  81. Cardiovascular fitness in young males and risk of unprovoked venous thromboembolism in adulthood
  82. Sibling risk of hospitalization for heart failure – A nationwide study
  83. Epidemiology of Familial Aggregation of Venous Thromboembolism
  84. Familial Transmission of Hospital-Treated Varicose Veins in Adoptees: A Swedish Family Study
  85. Venous thromboembolism and eye disease
  86. Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism
  87. Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis
  88. High Risk of Venous Thromboembolism in Klinefelter Syndrome
  89. Cognitive ability in Swedish conscripts and future risk of venous thromboembolism: A co-relative prospective national study
  90. Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: A national cohort study
  91. Familial risks of glomerulonephritis – a nationwide family study in Sweden
  92. A nationwide family study of venous thromboembolism and risk of arterial vascular disease
  93. Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism
  94. Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study
  95. Family history of venous thromboembolism is a risk factor for venous thromboembolism in combined oral contraceptive users: a nationwide case-control study
  96. Risk of breast cancer among patients with bioprosthetic or mechanical valve replacement: a population-based study in Sweden
  97. Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism
  98. Genetic aspects of thrombotic disease
  99. Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study
  100. Family history of venous thromboembolism as a risk factor and genetic research tool
  101. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence
  102. Perinatal risk factors for premature ischaemic heart disease in a Swedish national cohort
  103. Neighbourhood Deprivation, Individual-Level and Familial-Level Socio-demographic Factors and Risk of Congenital Heart Disease: A Nationwide Study from Sweden
  104. Familial transmission of chronic obstructive pulmonary disease in adoptees: a Swedish nationwide family study
  105. Impact of hypertension on the outcome of patients admitted with acute coronary syndrome
  106. Neighborhood Deprivation and Lung Cancer Incidence and Mortality: A Multilevel Analysis from Sweden
  107. Alcohol use disorders are associated with venous thromboembolism
  108. Familial Risks of Kidney Failure in Sweden: A Nationwide Family Study
  109. End stage renal disease risk and neighbourhood deprivation: A nationwide cohort study in Sweden
  110. The association between apolipoprotein M and insulin resistance varies with country of birth
  111. Circulating human epidermal growth factor receptor 2 (HER2) is associated with hyperglycaemia and insulin resistance循环中的人类表皮生长因子受体2(HER2)与高血糖以及胰岛素抵抗有关
  112. Familial transmission of prostate, breast and colorectal cancer in adoptees is related to cancer in biological but not in adoptive parents: A nationwide family study
  113. Venous Thromboembolism and Varicose Veins Share Familial Susceptibility: A Nationwide Family Study in Sweden
  114. Low degree of shared genetic susceptibility to coronary artery disease and venous thromboembolism
  115. Gestational Age and Risk of Venous Thromboembolism From Birth Through Young Adulthood
  116. Response to the Authors
  117. Neighborhood deprivation and childhood autism: A nationwide study from Sweden
  118. Familial Transmission of Venous Thromboembolism
  119. Risk of irritable bowel syndrome in first-degree, second-degree and thirddegree relatives of affected individuals: a nationwide family study in Sweden
  120. Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism
  121. Red cell distribution width and risk for venous thromboembolism: A population-based cohort study
  122. Family history of venous thromboembolism and risk of recurrent VTE
  123. Determination of 14 Circulating microRNAs in Swedes and Iraqis with and without Diabetes Mellitus Type 2
  124. Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism
  125. Neighborhood, family, and childhood and adolescent epilepsy: A nationwide epidemiological study from Sweden
  126. Neighbourhood Deprivation, Individual-Level Familial and Socio-Demographic Factors and Diagnosed Childhood Obesity: A Nationwide Multilevel Study from Sweden
  127. Nationwide Family Studies of Cardiovascular Diseases – Clinical and Genetic Implications of Family History
  128. Family history as a predictor of hospitalization for hypertension in Sweden
  129. Shared and non-shared familial susceptibility of coronary heart disease, ischemic stroke, peripheral artery disease and aortic disease
  130. Age-and sex-specific seasonal variation of venous thromboembolism in patients with and without family history: a nationwide family study in Sweden
  131. Low prevalence of irritable bowel syndrome in primary health care in four Swedish counties
  132. Shared and Nonshared Familial Susceptibility to Surgically Treated Inguinal Hernia, Femoral Hernia, Incisional Hernia, Epigastric Hernia, and Umbilical Hernia
  133. Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden
  134. Time trends in pulmonary embolism: A matter of age and gender
  135. Mothers, places and risk of hospitalization for childhood asthma: a nationwide study from Sweden
  136. Venous thromboembolism does not share strong familial susceptibility with pre‐eclampsia/eclampsia: a nationwide family study in Sweden
  137. Neighbourhood deprivation and hospitalization for atrial fibrillation in Sweden
  138. Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden
  139. Risk of hospitalization for type 2 diabetes in first- and second-generation immigrants in Sweden: a nationwide follow-up study
  140. Erratum to Zöller et al. "Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden"
  141. High Familial Risk of Atrial Fibrillation/Atrial Flutter in Multiplex Families: A Nationwide Family Study in Sweden
  142. Family history as a risk factor for recurrent hospitalization for lone atrial fibrillation: a nationwide family study in Sweden
  143. Neighborhood deprivation and risk of cervical cancer morbidity and mortality: A multilevel analysis from Sweden
  144. A nationwide family study of pulmonary embolism: Identification of high risk families with increased risk of hospitalized and fatal pulmonary embolism
  145. Risk of haemorrhagic and ischaemic stroke in patients with cancer: A nationwide follow-up study from Sweden
  146. Multiplex sibling history of coronary heart disease is a strong risk factor for coronary heart disease
  147. Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden
  148. Small and large PROS1 deletions but no other types of rearrangements detected in patients with protein S deficiency
  149. Family history and risk of hospital treatment for varicose veins in Sweden
  150. Socioeconomic and occupational risk factors for venous thromboembolism in Sweden: A nationwide epidemiological study
  151. Neighborhood deprivation and hospitalization for venous thromboembolism in Sweden
  152. Increased Risks of Coronary Heart Disease and Stroke Among Spousal Caregivers of Cancer Patients
  153. Risk of Subsequent Coronary Heart Disease in Patients Hospitalized for Immune-Mediated Diseases: A Nationwide Follow-Up Study from Sweden
  154. Occupational Risk Factors for Systemic Lupus Erythematosus: A Nationwide Study Based on Hospitalizations in Sweden
  155. Risk of venous thromboembolism in first- and second-generation immigrants in Sweden
  156. Risk of coronary heart disease in patients with cancer: A nationwide follow-up study from Sweden
  157. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden
  158. Shared familial aggregation of susceptibility to different manifestations of venous thromboembolism: a nationwide family study in Sweden
  159. Venous Thromboembolism Does Not Share Strong Familial Susceptibility With Ischemic Stroke
  160. Age- and Gender-Specific Familial Risks for Venous Thromboembolism
  161. Familial risk factors shared by venous thromboembolism and cancer: A nationwide epidemiological study of Swedish families
  162. Venous thromboembolism does not share strong familial susceptibility with coronary heart disease: a nationwide family study in Sweden
  163. Determination of age-specific and sex-specific familial risks for the different manifestations of venous thromboembolism: A nationwide family study in Sweden
  164. Parental history and venous thromboembolism: a nationwide study of age‐specific and sex‐specific familial risks in Sweden
  165. Familial risks of unusual forms of venous thrombosis: a nationwide epidemiological study in Sweden
  166. Large deletions of the PROS1 gene in a large fraction of mutationnegative patients with protein S deficiency
  167. Co‐segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1
  168. Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function
  169. Improved Hemoglobin Status and Reduced Menstrual Blood Loss among Female Carriers of Factor V Leiden – An Evolutionary Advantage?
  170. The Ala25-Thr Mutation in the Thrombomodulin Gene Is not Frequent in Swedish Patients Suffering from Ischemic Heart Disease
  171. Factor V Q506 (Resistance to Activated Protein C) and Prognosis after Acute Coronary Syndrome
  172. Clarification of the Risk for Venous Thrombosis Associated with Hereditary Protein S Deficiency by Investigation of a Large Kindred with a Characterized Gene Defect
  173. Resistance to activated protein C, the FV: Q506 allele, and venous thrombosis
  174. A New Direct, Fast and Quantitative Enzyme-linked Ligandsorbent Assay for Measurement of Free Protein S Antigen
  175. A Common 4G Allele in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene as a Risk Factor for Pulmonary Embolism and Arterial Thrombosis in Hereditary Protein S Deficiency
  176. ACTIVATED PROTEIN C RESISTANCE CAUSED BY A COMMON FACTOR V MUTATION HAS A SINGLE ORIGIN.
  177. ACTIVATED PROTEIN C RESISTANCE DUE TO A COMMON FACTOR V GENE MUTATION IS A MAJOR RISK FACTOR FOR VENOUS THROMBOSIS
  178. The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
  179. State-of-the-Art Review: Activated Protein C Resistance: Clinical Implications
  180. A Common Thrombomodulin Amino Acid Dimorphism Is Associated with Myocardial Infarction
  181. Evaluation of Original and Modified APC-Resistance Tests in Unselected Outpatients with Clinically Suspected Thrombosis and in Healthy Controls
  182. A Novel Thrombomodulin Gene Mutation in a Patient Suffering from Sagittal Sinus Thrombosis
  183. Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus
  184. Activated protein C resistance as a basis for venous thrombosis
  185. Editorial
  186. Resistance to activated protein C, the FV : Q 506 allele, and venous thrombosis
  187. Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries
  188. Resistance to activated protein C due to a factor V gene mutation
  189. Familial thrombophilia: Clinical and molecular analysis of Swedish families with inherited resistance to activated protein C or protein S deficiency
  190. Familial thrombophilia: Clinical and molecular analysis of Swedish families with inherited resistance to activated protein C or protein S deficiency
  191. Inherited resistance to activated protein C and venous thrombosis
  192. Inherited Resistance To Activated Protein C Caused By Presence Of The FV:Q506 Allele As A Basis Of Venous Thrombosis
  193. Actuated protein C resistance: From phenotype to genotype and clinical practice
  194. Resistance to activated protein C caused by a Factor V gene mutation
  195. Methodological Considerations on the Determination of the APC Response in Plasma
  196. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
  197. Myocardial infarction associated with homozygous resistance to activated protein C
  198. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis